Pentixapharm AG, a radiopharmaceutical development company wholly owned by Eckert & Ziegler SE, today announced that it has received encouraging feedback from the U.S. Food and Drug Administration (FDA) following a recent Type C meeting with the…
Berlin Center for Gene and Cell Therapies aspires to create a leading biotech ecosystem in Berlin / Federal Chancellor Scholz acknowledges the importance of the project for Germany / Governing Mayor of Berlin Kai Wegner assures support from the State…
Groundbreaking innovations by researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) provided the basis for the development of an antibody-drug conjugate (ADC) by the company Tubulis, which is now being used in a Phase I/IIa…
IDEA Studios will be strategically located in Asian and European innovation hubs to partner closely with early-stage companies focused on improving patient care
Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns…
Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the…
„Berlin is the best place for AI startups in Germany”
BERLIN, Germany, June 11, 2024 – Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announces the extension of its seed financing to over €14 M. This extension…
University ranks ninety-seventh in the world. According to this year’s QS World University Rankings, Freie Universität Berlin is among the top four universities in Germany. The rankings are published annually by higher education consulting firm…
• Regenerative Medicine Advanced Therapy (RMAT) designation follows phase I clinical trial results demonstrating that bemdaneprocel is well tolerated with no major safety issues through 18 months
• Bemdaneprocel is the most clinically advanced…
